These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study. Longatto-Filho A, Maeda MY, Erzen M, Branca M, Roteli-Martins C, Naud P, Derchain SF, Hammes L, Matos J, Gontijo R, Sarian LO, Lima TP, Tatti S, Syrjänen S, Syrjänen K. Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026 [Abstract] [Full Text] [Related]
5. Cervical pre-malignant lesions in HIV infected women attending Care and Treatment Centre in a tertiary hospital, Dar es Salaam, Tanzania. Balandya BS, Pembe AB, Mwakyoma HA. East Afr J Public Health; 2011 Sep; 8(3):185-9. PubMed ID: 23120953 [Abstract] [Full Text] [Related]
7. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Sahasrabuddhe VV, Bhosale RA, Kavatkar AN, Nagwanshi CA, Joshi SN, Jenkins CA, Shepherd BE, Kelkar RS, Sahay S, Risbud AR, Vermund SH, Mehendale SM. Int J Cancer; 2012 Jan 01; 130(1):234-40. PubMed ID: 21387289 [Abstract] [Full Text] [Related]
10. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic. Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C. Eur J Gynaecol Oncol; 2004 Jan 01; 25(5):577-84. PubMed ID: 15493169 [Abstract] [Full Text] [Related]
11. Should all women with cervical atypia be referred for colposcopy: a HARNET study. Harrisburgh Area Research Network. Slawson DC, Bennett JH, Simon LJ, Herman JM. J Fam Pract; 1994 Apr 01; 38(4):387-92. PubMed ID: 8163964 [Abstract] [Full Text] [Related]
12. Visual inspection with acetic acid for cervical cancer screening outside of low-resource settings. Jeronimo J, Morales O, Horna J, Pariona J, Manrique J, Rubiños J, Takahashi R. Rev Panam Salud Publica; 2005 Jan 01; 17(1):1-5. PubMed ID: 15720875 [Abstract] [Full Text] [Related]
13. Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. Bateman AC, Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Kapambwe S, Katundu K, Nkole T, Mulundika J, Pfaendler KS, Hicks ML, Shibemba A, Vermund SH, Stringer JS, Chibwesha CJ. J Acquir Immune Defic Syndr; 2014 Oct 01; 67(2):212-5. PubMed ID: 24977474 [Abstract] [Full Text] [Related]
14. Amplification of specific chromosomal regions assessed by fluorescent in situ hybridization on Pap smears to be added as screening tool for identifying women at risk of progressing to cervical cancer. Upendram P, Sahni S, Mohiuddin K, Poornima S, Gourishankar B, Kumar Vattam K, Boddala P, Jayashankar E, Mohiuddin S, Kamineni V, Mohan V, Houldsworth J, Hasan Q. Tumour Biol; 2017 Oct 01; 39(10):1010428317698363. PubMed ID: 28990460 [Abstract] [Full Text] [Related]
15. Prevalence and correlates of cervical squamous intraepithelial lesions among HIV-infected and uninfected women in Central Kenya. Njagi SK, Ngure K, Mwaniki L, Kiptoo M, Mugo NR. Pan Afr Med J; 2021 Oct 01; 39():44. PubMed ID: 34422167 [Abstract] [Full Text] [Related]
16. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness. Kaufman RH, Adam E, Icenogle J, Reeves WC. Am J Obstet Gynecol; 1997 Oct 01; 177(4):930-6. PubMed ID: 9369847 [Abstract] [Full Text] [Related]